Previous symbols: PARK9. Aliases: HSA9947, CLN12.
ai-gene-review has this gene at status DRAFT; the description is shown only once the review is complete. Read the draft upstream.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Juvenile Neuronal Ceroid Lipofuscinosis | causative germline |
mechanism: ATP13A2 transmembrane protein dysfunction; Lysosomal Ceroid-Lipofuscin Storage
subtype: CLN12 disease, late juvenile onset
scoped to subtype: CLN12 disease, late juvenile onset
|
| Complex Hereditary Spastic Paraplegia | untyped |
mechanism: Endolysosomal and ESCRT Membrane-Traffic Failure
subtype: SPG78
scoped to subtype: SPG78
|
| Kufor-Rakeb syndrome |
untyped
Loss-of-function
|
mechanism: ATP13A2 loss impairs lysosomal polyamine transport
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| Kufor-Rakeb syndrome MONDO:0011706 | AR | Definitive 2022-04-14 |
Kufor-Rakeb syndrome
untyped
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.